论文信息 - Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework - 字舞流文

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

A. Drzezga | O. Hansson | A. Nordberg | R. Ossenkoppele | O. Sabri | H. Barthel | M. Boccardi | G. Bischof | V. Garibotto | T. van Eimeren | C. Festari | A. Dodich | B. F. Giovanni